Clinical Trial Update: First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain [EARLY_Phase 1]

View source ↗

Summary

First-in-human safety and evaluation study of two 4R tau PET radioligands for brain imaging, with recruitment ongoing in Progressive Supranuclear Palsy patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• 4R Tau Ligand A
• 4R Tau Ligand B

Snippet

Sponsor: Invicro | Conditions: Progressive Supranuclear Palsy (PSP), Healthy Participants | EARLY_Phase 1 | Status: RECRUITING